Cultura Technologies acquires TOPAZ Technologies
Cultura Technologies enters biosciences research industry with the acquisition of TOPAZ Technologies LLC, Austin, Texas
Toronto, Canada, 21st June 2016 – Cultura Technologies LLC today announced that it has entered into the biosciences research industry through the acquisition of TOPAZ Technologies LLC, Austin Texas.
For over 30 years TOPAZ has developed pre-clinical and clinical software solutions for the medical research industry. TOPAZ is recognized as a market leader in providing highly specialized solutions for complex regulatory environments managed by University research facilities, Pharmaceutical companies, and government research institutions.
“Cultura is committed to providing a diversified portfolio of solutions within the biosciences industry,” said James Baker, President, Cultura Technologies. “The acquisition of TOPAZ helps us deliver on this vision by securing a presence in the increasingly important research industry”. We are excited to welcome the TOPAZ team and its customers to Cultura.”
“As the pre-clinical and clinical research sector continues to develop and globalize I am very pleased to have found a new home for TOPAZ Technologies to further develop our leadership position in this industry”, added Mr. Ron Thornton, CEO TOPAZ Technologies LLC. He continued by saying, “Customers can expect to receive continued support and development of their existing TOPAZ software solutions with existing management and staff but now under the guidance of a global reaching vertical software organization”.
Cultura Technologies LLC is a subsidiary of Constellation Software, Inc. (CSI), headquartered in Toronto, Ontario, Canada. CSI is an international provider of market-leading software and services for the public and private sectors and has over 10,000 employees globally today. Cultura Technologies provides software solutions to leading Agri-businesses and food processors throughout North America, the UK, and Europe.
About TOPAZ Technologies
TOPAZ Technologies is a market-leading biomedical research solutions provider addressing the complex business, operational, and compliance needs of the Life Sciences industry. Founded in 1980 and operating internationally, TOPAZ Technologies software solutions help all segments of the biomedical research market transform operations for improved efficiency, compliance protection, and operational insight. With a keen focus on customer service and unmatched product depth, TOPAZ Technologies has an expansive customer list which includes many of the largest medical research organizations around the globe, including pharmaceutical, academic and government institutions.
For more information, visit https://www.topazti.com